Steven Cohen's IMNM Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 7.03 M shares of Immunome, Inc. (IMNM) worth $151.11 M, representing 0.17% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in IMNM, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 3.67 M shares. Largest reduction occurred in Q2 2024, reducing 1.26 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Immunome (IMNM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Immunome (IMNM) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +2.21 M | Add 45.82% | 7.03 M | $21.48 |
| Q3 2025 | +138,701 | Add 2.96% | 4.82 M | $11.71 |
| Q2 2025 | +325,128 | Add 7.46% | 4.69 M | $9.30 |
| Q1 2025 | +3.67 M | Add 533.09% | 4.36 M | $6.73 |
| Q4 2024 | +218,143 | Add 46.35% | 688,790 | $10.62 |
| Q3 2024 | +85,580 | Add 22.22% | 470,647 | $14.62 |
| Q2 2024 | -1.26 M | Reduce 76.55% | 385,067 | $12.10 |
| Q1 2024 | +959,281 | Add 140.53% | 1.64 M | $24.68 |
| Q4 2023 | +136,700 | Add 25.04% | 682,619 | $10.70 |
| Q3 2023 | +127,792 | Add 30.56% | 545,919 | $8.35 |
| Q2 2023 | +418,127 | New Buy | 418,127 | $7.91 |
Steven Cohen's Immunome Investment FAQs
Steven Cohen first purchased Immunome, Inc. (IMNM) in Q2 2023, acquiring 418,127 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Immunome, Inc. (IMNM) for 11 quarters since Q2 2023.
Steven Cohen's largest addition to Immunome, Inc. (IMNM) was in Q1 2025, adding 4,360,675 shares worth $29.35 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 7,034,952 shares of Immunome, Inc. (IMNM), valued at approximately $151.11 M.
As of the Q4 2025 filing, Immunome, Inc. (IMNM) represents approximately 0.17% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Immunome, Inc. (IMNM) was 7,034,952 shares, as reported at the end of Q4 2025.